CNMD

CONMED

CNMD

Attention (50-day avg)0%

Attention rank (50-day avg)#3,222

Bullish sentiment (50-day avg)100%

Price to earnings ratio24.5

Market capitalization1.4B

Earnings per share1.85

Dividend yield (TTM)1.72%

Revenue (annual)1.4B

Net income (annual)47.1M

Social

What share of all stock conversation is about CNMD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Aug 3

CONMED Corporation's stock price has increased by 18% according to a post highlighting the return.
The stock has seen a significant intraday increase of 13.7% with a current price of $52.62 on average volume.
Piper Jaffray has initiated coverage on CONMED Corporation with a price target of $34, citing a lack of catalysts.

Generated by AI

Sentiment

Of the messages about CNMD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100% 0	76.79% -10.93
Bearish	0%	0%	0% 0	23.21% +10.93

Oct 31

Upgrades to CONMED Corporation's stock rating by Zacks Investment Research suggest increased analyst confidence in the company's future performance.
This upgrade may lead to increased investor interest and potential price appreciation for CONMED Corporation's stock.
The upgraded rating could also contribute to a reevaluation of CONMED Corporation's growth prospects and potential for long-term gains.

Generated by AI

Topics

Of the messages about CNMD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	68.75%
Technical Analysis	—	—	—	5%
Earnings	—	—	—	3.75%
Analysts	—	—	—	21.25%
Controversies	—	—	—	0%
Macro	—	—	—	1.25%

Nov 1

CONMED Corporation ($CNMD) reported FQ3 earnings of 46c EPS, beating the Estimize EPS Consensus by 1c.
$CNMD also beat the Estimize Revenue Consensus by $1.71M, reporting $202.31M in revenue.
The company guided FY18 EPS in-line and raised the low end of adjusted sales growth.

Generated by AI

Community

Of the messages about CNMD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	17.47%
Newcomers	100%	100%	100%	82.53%

Regulars· Feb 1

CONMED Corporation's stock ($CNMD) traded 377% above average volume and was down -13.07% in the last session.
Analyst Robbie Marcus of JPMORGAN downgraded $CNMD from $135 to $115, decreasing potential upside, with a rating of Overweight.
Needham raised CONMED's price target to $129, maintaining a Buy rating, while Wells Fargo lowered its target to $98, maintaining an Equal Weight rating.

Newcomers· Aug 3

Newcomers are focusing on the potential for Conmed Corporation ($CNMD) to increase in value, with one user noting an 18% return on a call option.
There is interest in Conmed Corporation's upcoming call option expiring on August 26, with a price of $1.10.
Users are tracking Conmed Corporation's performance, with one user noting a 13.7% intraday increase and another mentioning the company's current price at $52.62.

Generated by AI

News

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.

13d agoYahoo Finance

CONMED at Wells Fargo conference: growth story gains momentum

20d agoInvesting.com

Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

1mo agoYahoo Finance

CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference

LARGO, Fla., August 26, 2026--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA.

1mo agoYahoo Finance

CONMED Corporation: Organic Growth Is Masked By Divestitures (NYSE:CNMD)

1mo agoSeeking Alpha

The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio

Recently, CONMED Corporation was highlighted for its positioning in differentiated surgical platforms such as AirSeal, Buffalo Filter, and BioBrace, with these products benefiting from supportive regulatory trends and growing clinical adoption, while the company continues to face risks from tariffs and slower expansion in specific platforms like AirSeal. An interesting angle is that regulatory momentum around operating room air quality and clinician willingness to adopt newer biomaterials...

1mo agoYahoo Finance

Also Discussed

Investors talking about CNMD also mention

#	Name	Attention
1	United Community Banks, Inc.UCBI	0%new
2	Integra LifeSciences Holdings CorporationIART	0%0
3	Teleflex IncorporatedTFX	0%+0
4	ICU Medical, Inc.ICUI	0%0
5	Globus Medical Inc. Class A Common StockGMED	0%new
6	Hawthorn Bancshares Inc.HWBK	0%0
7	STAAR Surgical CompanySTAA	0%new
8	NUVA - NuVasive, Inc.	——
9	TriCo BancsharesTCBK	0%0
10	C&F Financial CorpCFFI	0%0

CONMED Corporation

Healthcare
Medical Devices

CONMED Corporation is a medical technology company that develops, manufactures, and sells surgical devices and equipment used in hospitals, ambulatory surgery centers, and other clinical settings. The company’s portfolio supports minimally invasive procedures across orthopedic surgery, general surgery, gynecology, thoracic surgery, and gastroenterology. Its products include surgical instruments, endoscopic technologies, electrosurgical systems, fixation devices, patient positioning solutions, and monitoring accessories designed to help healthcare professionals perform a wide range of procedures. CONMED Corporation serves medical providers in the United States and international markets, positioning itself as a specialist in operating-room technologies and procedural support tools. Based in Largo, Florida, CONMED Corporation focuses on products that are used throughout the surgical workflow, from access and visualization to treatment and patient care.

Website

Location

11311 Concept Boulevard

Largo, FL, 33773

United States

Social

What share of all stock conversation is about CNMD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% 0	0% 0

Aug 3

CONMED Corporation's stock price has increased by 18% according to a post highlighting the return.
The stock has seen a significant intraday increase of 13.7% with a current price of $52.62 on average volume.
Piper Jaffray has initiated coverage on CONMED Corporation with a price target of $34, citing a lack of catalysts.

Generated by AI

Sentiment

Of the messages about CNMD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100%	100% 0	76.79% -10.93
Bearish	0%	0%	0% 0	23.21% +10.93

Oct 31

Upgrades to CONMED Corporation's stock rating by Zacks Investment Research suggest increased analyst confidence in the company's future performance.
This upgrade may lead to increased investor interest and potential price appreciation for CONMED Corporation's stock.
The upgraded rating could also contribute to a reevaluation of CONMED Corporation's growth prospects and potential for long-term gains.

Generated by AI

Topics

Of the messages about CNMD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	—	68.75%
Technical Analysis	—	—	—	5%
Earnings	—	—	—	3.75%
Analysts	—	—	—	21.25%
Controversies	—	—	—	0%
Macro	—	—	—	1.25%

Nov 1

CONMED Corporation ($CNMD) reported FQ3 earnings of 46c EPS, beating the Estimize EPS Consensus by 1c.
$CNMD also beat the Estimize Revenue Consensus by $1.71M, reporting $202.31M in revenue.
The company guided FY18 EPS in-line and raised the low end of adjusted sales growth.

Generated by AI

Community

Of the messages about CNMD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	17.47%
Newcomers	100%	100%	100%	82.53%

Regulars· Feb 1

CONMED Corporation's stock ($CNMD) traded 377% above average volume and was down -13.07% in the last session.
Analyst Robbie Marcus of JPMORGAN downgraded $CNMD from $135 to $115, decreasing potential upside, with a rating of Overweight.
Needham raised CONMED's price target to $129, maintaining a Buy rating, while Wells Fargo lowered its target to $98, maintaining an Equal Weight rating.

Newcomers· Aug 3

Newcomers are focusing on the potential for Conmed Corporation ($CNMD) to increase in value, with one user noting an 18% return on a call option.
There is interest in Conmed Corporation's upcoming call option expiring on August 26, with a price of $1.10.
Users are tracking Conmed Corporation's performance, with one user noting a 13.7% intraday increase and another mentioning the company's current price at $52.62.

Generated by AI

CONMED

Social

Aug 3

Oct 31

Nov 1

Regulars· Feb 1

Newcomers· Aug 3

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CONMED at Wells Fargo conference: growth story gains momentum

Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?

CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference

CONMED Corporation: Organic Growth Is Masked By Divestitures (NYSE:CNMD)

The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio

Also Discussed

CONMED Corporation

Company Information

Location

Social

Aug 3

Oct 31

Nov 1

Regulars· Feb 1

Newcomers· Aug 3

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CONMED at Wells Fargo conference: growth story gains momentum

Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?

CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference

CONMED Corporation: Organic Growth Is Masked By Divestitures (NYSE:CNMD)

The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio

Also Discussed